AbbVie And Valkai Collaborate To Accelerate Pace Of Scientific Innovation's Reach To Patients

AbbVie (NYSE: ABBV) has announced a partnership with Valkai, a life sciences AI platform, to enhance its artificial intelligence infrastructure. This collaboration aims to accelerate the delivery of scientific innovations to patients by improving efficiency in clinical research and reducing development timelines.